⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5315076 | 0.80 | — | — | |
| SCHEMBL5983734 | 0.80 | — | — | |
| SCHEMBL5983730 | 0.80 | — | — | |
| SCHEMBL28101648 | 0.75 | CA1 (0.33) | — | |
| SCHEMBL8090347 | 0.75 | — | — | |
| SCHEMBL7521024 | 0.73 | — | — | |
| SCHEMBL7860237 | 0.73 | — | — | |
| SCHEMBL332484 | 0.73 | — | — | |
| SCHEMBL7524232 | 0.73 | — | — | |
| SCHEMBL7514559 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 225 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021158891-A1 | SALTS AND SOLID FORMS AND PROCESSES OF PREPARING A PI3K INHIBITOR | INCYTE CORPORATION (US) | 2021-08-12 | — | — | WO | claimed |
| CN-111333598-A | Synthesis method of R-3-propyl-gamma-butyrolactone | 武汉利昌医药科技有限公司 | 2020-06-26 | — | — | CN | claimed |
| WO-2020128469-A1 | SYNTHESIS OF 8-CHLOROADENOSINE DERIVATIVES INCLUDING NUC-9701 | NuCana plc (GB) | 2020-06-25 | — | — | WO | claimed |
| CN-110129580-A | A kind of method that soaking while grinding and its equipment strengthens the leaching of chalcopyrite normal pressure organic halogenation | 东北大学 | 2019-08-16 | — | — | CN | claimed |
| CN-105503882-B | The method for preparing S1P1 receptor modulators and its crystal form | 艾尼纳制药公司 | 2019-07-05 | — | — | CN | claimed |
| CN-109516905-A | The preparation method of inexpensive dihydro jasmone | 盐城市春竹香料有限公司 | 2019-03-26 | — | — | CN | claimed |
| CN-108602765-A | Method for producing 1, 2-benzenedimethanol compound | SDS生物技术株式会社 | 2018-09-28 | — | — | CN | claimed |
| CN-108467766-A | A kind of engine repair agent | 温州巨耀汽车服务有限公司 | 2018-08-31 | — | — | CN | claimed |
| CN-108435132-A | A kind of auxiliary agent improving fluid catalytic cracking product yield | 广东石油化工学院 | 2018-08-24 | — | — | CN | claimed |
| CN-108290903-A | New big ring sulphonyl diimine compounds | 拜耳医药股份有限公司 | 2018-07-17 | — | — | CN | claimed |
| WO-2018104953-A1 | IMPROVED PROCESS FOR THE PREPARATION OF 7-{4-[4-(2,3-DICHLOROPHENYL)-PIPERAZIN-1-YL]BUTOXY}-2OXO-3,4-DIHYDRO-2H-QUINOLIN-1-YL)METHYL DODECANOATE | MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) | 2018-06-14 | — | — | WO | claimed |
| CN-105593214-B | Method for synthesizing N-benzyl-N-cyclopropyl-1H-pyrazole-4-formamide derivative | 拜耳作物科学股份公司 | 2018-05-29 | — | — | CN | claimed |
| CN-106687462-A | Processes of preparing a jak1 inhibitor and new forms thereto | 因赛特公司 | 2017-05-17 | — | — | CN | claimed |
| CN-106467448-A | For the alkene polymerization inhibitor in methanol-to-olefins device caustic wash tower | 中国石油化工股份有限公司 | 2017-03-01 | — | — | CN | claimed |
| CN-106467447-A | The method of olefinic polymerization in suppression methanol-to-olefins device caustic wash tower | 中国石油化工股份有限公司 | 2017-03-01 | — | — | CN | claimed |
| WO-2014163933-A1 | PROCESS FOR PREPARATION OF TRIARYL PESTICIDE INTERMEDIATE | DOW AGROSCIENCES LLC (US) | 2014-10-09 | — | — | WO | claimed |
| EP-1814857-A1 | ISOTOPICALLY MARKED QUINOLINE DERIVATIVES AS ADENOSIN A3 RECEPTOR LIGANDS | Sanofi-Aventis (FR) | 2007-08-08 | — | — | EP | claimed |
| WO-2006083417-A2 | PROCESSES OF MAKING SESQUITERPENOID TASHIRONIN, ITS ANALOGS AND THEIR USES | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2006-08-10 | — | — | WO | claimed |
| WO-2006051341-A1 | ISOTOPICALLY MARKED QUINOLINE DERIVATIVES AS ADENOSIN A3 RECEPTOR LIGANDS | SANOFI-AVENTIS (FR) | 2006-05-18 | — | — | WO | claimed |
| CN-112300172-B | Bruton tyrosine kinase inhibitors | 比奥根MA公司 | 2024-01-16 | — | — | CN | disclosed |
| WO-2023205344-A1 | SMALL MOLECULE MODULATORS OF HUMAN PREGNANE X RECEPTOR | ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) | 2023-10-26 | — | — | WO | disclosed |
| EP-4013495-A1 | ARYLSULFONAMIDE DERIVATIVES AS MGLUR4 NEGATIVE ALLOSTERIC MODULATORS | F. Hoffmann-La Roche AG (CH) | 2022-06-22 | — | — | EP | disclosed |
| EP-3965760-A1 | SYNTHESIS OF CRAC CHANNEL INHIBITORS | Calcimedica, Inc. (US) | 2022-03-16 | — | — | EP | disclosed |
| EP-3953331-A1 | PYRAZOLESULFONAMIDES AS ANTITUMOR AGENTS | Peloton Therapeutics, Inc. (US) | 2022-02-16 | — | — | EP | disclosed |
| WO-2021158891-A1 | SALTS AND SOLID FORMS AND PROCESSES OF PREPARING A PI3K INHIBITOR | INCYTE CORPORATION (US) | 2021-08-12 | — | — | WO | disclosed |
| EP-3484875-B1 | PYRAZOLYLAMINOBENZIMIDAZOLE DERIVATIVES AS JAK INHIBITORS | LILLY CO ELI (US) | 2021-04-07 | — | — | EP | disclosed |
| WO-2021028512-A1 | ARYLSULFONAMIDE DERIVATIVES AS MGLUR4 NEGATIVE ALLOSTERIC MODULATORS | F. HOFFMANN-LA ROCHE AG (CH) | 2021-02-18 | — | — | WO | disclosed |
| WO-2020227592-A1 | THIOSEMICARBAZATES AND USES THEREOF | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2020-11-12 | — | — | WO | disclosed |
| WO-2020210139-A1 | PYRAZOLESULFONAMIDES AS ANTITUMOR AGENTS | PELOTON THERAPEUTICS, INC. (US) | 2020-10-15 | — | — | WO | disclosed |
| WO-2020157710-A1 | 4-SUBSTITUTED ISOXAZOLE/ISOXAZOLINE (HETERO) ARYLAMIDINE COMPOUNDS, PREPARATION AND USE THEREOF | PI INDUSTRIES LTD. (IN) | 2020-08-06 | — | — | WO | disclosed |
| CN-111333598-A | Synthesis method of R-3-propyl-gamma-butyrolactone | 武汉利昌医药科技有限公司 | 2020-06-26 | — | — | CN | disclosed |
| EP-3298001-B1 | DGAT2 INHIBITORS | LILLY CO ELI (US) | 2020-05-13 | — | — | EP | disclosed |
| CN-110506043-A | COMPOUNDS USEFUL AS RET INHIBITORS | CANCER RES TECH LIMITED | 2019-11-26 | — | — | CN | disclosed |
| CN-107207432-B | Pyrroles's sulphonyl analog derivative, preparation method and its application in medicine | 江苏柯菲平医药股份有限公司 | 2019-09-17 | — | — | CN | disclosed |
| CN-110230071-A | A method of β-halo carbonyl compounds are prepared using high-salt wastewater | 上海交通大学 | 2019-09-13 | — | — | CN | disclosed |
| CN-110129580-A | A kind of method that soaking while grinding and its equipment strengthens the leaching of chalcopyrite normal pressure organic halogenation | 东北大学 | 2019-08-16 | — | — | CN | disclosed |
| CN-106467448-B | For the alkene polymerization inhibitor in methanol-to-olefins device caustic wash tower | 中国石油化工股份有限公司 | 2019-08-06 | — | — | CN | disclosed |
| EP-3515903-A1 | PREPARATION AND USES OF PYRIMIDINONE DERIVATIVES | Cancer Research Technology Limited (GB) | 2019-07-31 | — | — | EP | disclosed |
| CN-110072847-A | 1,3- dipolar compound with conjugation carbon-to-carbon double bond | 米其林集团总公司 | 2019-07-30 | — | — | CN | disclosed |
| US-10344018-B2 | Pyrazolylaminobenzimidazole derivatives as JAK inhibitors | ELI LILLY AND COMPANY (US) | 2019-07-09 | — | — | US | disclosed |
| CN-109983001-A | 2, 5-disubstituted 3-methylpyrazine and 2,5, 6-trisubstituted 3-methylpyrazine as allosteric SHP2 inhibitors | 锐新医药公司 | 2019-07-05 | — | — | CN | disclosed |
| CN-105503882-B | The method for preparing S1P1 receptor modulators and its crystal form | 艾尼纳制药公司 | 2019-07-05 | — | — | CN | disclosed |
| CN-106990079-B | A kind of surface multifunctional coating and the preparation method and application thereof | 中国科学院化学研究所 | 2019-06-25 | — | — | CN | disclosed |
| US-10323019-B2 | Pyrazolylaminobenzimidazole derivatives as JAK inhibitors | ELI LILLY AND COMPANY (US) | 2019-06-18 | — | — | US | disclosed |
| CN-109890208-A | FUNGICIDAL COMPOSITIONS | 先正达参股股份有限公司 | 2019-06-14 | — | — | CN | disclosed |
| US-20190177300-A1 | PYRAZOLYLAMINOBENZIMIDAZOLE DERIVATIVES AS JAK INHIBITORS | LILLY CO ELI (US) | 2019-06-13 | — | — | US | disclosed |
| CN-109803962-A | Modulators of cystic fibrosis transmembrane conductance regulator proteins, pharmaceutical compositions, methods of treatment, and methods for making the modulators | 弗特克斯药品有限公司 | 2019-05-24 | — | — | CN | disclosed |
| EP-3484875-A1 | PYRAZOLYLAMINOBENZIMIDAZOLE DERIVATIVES AS JAK INHIBITORS | Eli Lilly and Company (US) | 2019-05-22 | — | — | EP | disclosed |
| CN-105176641-B | A kind of lubricant oil composite and preparation method thereof of tractor three | 中国石油化工股份有限公司 | 2019-04-16 | — | — | CN | disclosed |
| CN-109563062-A | The manufacture of sulfonyl azide acid anhydrides | 陶氏环球技术有限责任公司 | 2019-04-02 | — | — | CN | disclosed |
| CN-107428935-B | Diamine compound, heat-resistant resin or heat-resistant resin precursor using it | 东丽株式会社 | 2019-04-02 | — | — | CN | disclosed |
| CN-109516905-A | The preparation method of inexpensive dihydro jasmone | 盐城市春竹香料有限公司 | 2019-03-26 | — | — | CN | disclosed |
| CN-106414442-B | 1H- pyrrolo- [2,3-c] pyridine -7 (6H) -one and pyrazolo [3,4-c] pyridine -7 (6H) -one as BET protein inhibitor | 因赛特公司 | 2019-03-15 | — | — | CN | disclosed |
| CN-103819467-B | The preparation method and its usage of quinazoline derivant | 中国科学院福建物质结构研究所 | 2019-03-08 | — | — | CN | disclosed |
| CN-109414680-A | Functionalized chromatography media comprising polymeric nanofibers and methods of making the same | 纯化迪发有限公司 | 2019-03-01 | — | — | CN | disclosed |
| WO-2018234353-A1 | NOVEL SUBSTITUTED INDOLE AND INDAZOLE COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS | Grünenthal GmbH (DE) | 2018-12-27 | — | — | WO | disclosed |
| CN-109071533-A | Halogenated allylamine indoles and 7-azaindole derivatives inhibitor of lysyloxidase and application thereof | 法玛西斯有限公司 | 2018-12-21 | — | — | CN | disclosed |
| CN-109071504-A | Inhibitors of receptor interacting protein kinase 1 | 戴纳立制药公司 | 2018-12-21 | — | — | CN | disclosed |
| CN-105705510-B | HCV polymerase inhibitors | 美迪维尔公司 | 2018-11-30 | — | — | CN | disclosed |
| CN-108884035-A | Indolo-substituted piperidines as estrogen receptor degraders | 罗欣生物科技（上海）有限公司 | 2018-11-23 | — | — | CN | disclosed |
| US-20180325873-A1 | PYRAZOLYLAMINOBENZIMIDAZOLE DERIVATIVES AS JAK INHIBITORS | ELI LILLY AND COMPANY | 2018-11-15 | — | — | US | disclosed |
| CN-108699028-A | It is substituted 4- phenylpyridine compounds as non-systemic TGR5 agonists | 阿德利克斯公司 | 2018-10-23 | — | — | CN | disclosed |
| CN-105451558-B | Pyrazolyl pyrrolinone and its purposes as herbicide | 先正达参股股份有限公司 | 2018-10-23 | — | — | CN | disclosed |
| CN-108676047-A | Hcv polymerase inhibitors | 美迪维尔公司 | 2018-10-19 | — | — | CN | disclosed |
| CN-108602765-A | Method for producing 1, 2-benzenedimethanol compound | SDS生物技术株式会社 | 2018-09-28 | — | — | CN | disclosed |
| CN-103601762-B | Ferrocene derivatives, preparation method and its usage | 中国科学院福建物质结构研究所 | 2018-09-28 | — | — | CN | disclosed |
| CN-108558973-A | Hcv polymerase inhibitors | 美迪维尔公司 | 2018-09-21 | — | — | CN | disclosed |
| WO-2018167801-A1 | NOVEL TRICYCLIC COMPOUNDS, PROCESS FOR PREPARATION AND USE THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2018-09-20 | — | — | WO | disclosed |
| CN-108495898-A | Double imide with rigidity 2,2 '-biphenylyloxies bridge joint | 巴斯夫欧洲公司 | 2018-09-04 | — | — | CN | disclosed |
| CN-108473469-A | Substituted 3-azabicyclo [3.1.0] hexanes as ketohexokinase inhibitors | 辉瑞公司 | 2018-08-31 | — | — | CN | disclosed |
| CN-108435132-A | A kind of auxiliary agent improving fluid catalytic cracking product yield | 广东石油化工学院 | 2018-08-24 | — | — | CN | disclosed |
| EP-3362423-A1 | DEUTERATED CHLOROKYNURENINES FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS | Auspex Pharmaceuticals, Inc. (US) | 2018-08-22 | — | — | EP | disclosed |
| US-10053429-B2 | DGAT2 inhibitors | ELI LILLY AND COMPANY (US) | 2018-08-21 | — | — | US | disclosed |
| CN-108430986-A | fused bicyclic heterocyclic derivatives as pest control agents | 拜耳作物科学股份公司 | 2018-08-21 | — | — | CN | disclosed |
| CN-108290838-A | Biaryl derivatives and drugs containing the same | 科研制药株式会社 | 2018-07-17 | — | — | CN | disclosed |
| CN-108290903-A | New big ring sulphonyl diimine compounds | 拜耳医药股份有限公司 | 2018-07-17 | — | — | CN | disclosed |
| EP-3074381-B1 | NOVEL DGAT2 INHIBITORS | LILLY CO ELI (US) | 2018-07-04 | — | — | EP | disclosed |
| CN-108191870-A | For benzimidazole simultaneously [1,2-A] benzimidizole derivatives of electronic application | UDC 爱尔兰有限责任公司 | 2018-06-22 | — | — | CN | disclosed |
| CN-108191719-A | A kind of chalcone analog, preparation method and its medical usage of the substitution of class containing sulfone | 中国药科大学 | 2018-06-22 | — | — | CN | disclosed |
| US-20180162825-A1 | NOVEL DGAT2 INHIBITORS | ELI LILY AND COMPANY (US) | 2018-06-14 | — | — | US | disclosed |
| CN-108102774-A | A kind of lubricating oil and its application | 金雪驰科技（马鞍山）有限公司 | 2018-06-01 | — | — | CN | disclosed |
| CN-104870430-B | Herbicidally active cyclic dione compounds substituted by phenyl groups having alkynyl-containing substituents or derivatives thereof | 先正达有限公司 | 2018-05-29 | — | — | CN | disclosed |
| CN-105593214-B | Method for synthesizing N-benzyl-N-cyclopropyl-1H-pyrazole-4-formamide derivative | 拜耳作物科学股份公司 | 2018-05-29 | — | — | CN | disclosed |
| CN-108003991-A | A kind of plant based lubricating oil and its application | 金雪驰科技（马鞍山）有限公司 | 2018-05-08 | — | — | CN | disclosed |
| CN-107922380-A | Microbicidal heterobicyclic derivatives | 先正达参股股份有限公司 | 2018-04-17 | — | — | CN | disclosed |
| CN-107922408-A | Microbicidal heterobicyclic derivatives | 先正达参股股份有限公司 | 2018-04-17 | — | — | CN | disclosed |
| WO-2018055402-A1 | PREPARATION AND USES OF PYRIMIDINONE DERIVATIVES | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2018-03-29 | — | — | WO | disclosed |
| CN-107848988-A | Alkenyl substituted 2, 5-piperazinediones and their use in compositions for delivering an agent to a subject or cell | 麻省理工学院 | 2018-03-27 | — | — | CN | disclosed |
| CN-107849022-A | SUBSTITUTED QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF | 亚瑞克西斯制药公司 | 2018-03-27 | — | — | CN | disclosed |
| CN-104507945-B | Pyrrolo- [2,3 B] pyrazine as SYK inhibitor | 霍夫曼-拉罗奇有限公司 | 2018-03-23 | — | — | CN | disclosed |
| CN-107820497-A | Imidazoles pyrazines derivatives for electronic installation | 陶氏环球技术有限责任公司 | 2018-03-20 | — | — | CN | disclosed |
| CN-105324372-B | 1-sulfonylpiperidine derivatives as prokineticin receptor modulators | 武田药品工业株式会社 | 2018-03-06 | — | — | CN | disclosed |
| CN-105683188-B | The ring pyridinyl derivatives of condensed ring two as FGFR4 inhibitor | 诺华股份有限公司 | 2018-02-09 | — | — | CN | disclosed |
| CN-107635975-A | NOVEL DGAT2 INHIBITORS | 伊莱利利公司 | 2018-01-26 | — | — | CN | disclosed |
| CN-104395316-B | Benzimidazo [1,2-A ] benzimidazole derivatives for electronic applications | UDC 爱尔兰有限责任公司 | 2018-01-19 | — | — | CN | disclosed |
| CN-105820128-B | A kind of preparation method of cyproconazole | 江西华士药业有限公司 | 2018-01-19 | — | — | CN | disclosed |
| CN-105339347-B | The ring dione compounds and its derivative of (alkynyl phenyl) substitution of activity of weeding | 先正达有限公司 | 2018-01-19 | — | — | CN | disclosed |
| WO-2018013486-A1 | PYRAZOLYLAMINOBENZIMIDAZOLE DERIVATIVES AS JAK INHIBITORS | ELI LILLY AND COMPANY (US) | 2018-01-18 | — | — | WO | disclosed |
| CN-107531739-A | Nucleotide derivative as the HCV inhibitor for treating hepatitis C | 美迪维尔公司 | 2018-01-02 | — | — | CN | disclosed |
| EP-3259253-A1 | SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME | The University of Queensland (AU) | 2017-12-27 | — | — | EP | disclosed |
| CN-103946220-B | Inhibitors of baculovirus containing fragment {2- [4- (biphenyl-4-yl) -1H-imidazol-2-yl ] pyrrolidine-1-carbonylmethyl } amine | 施万生物制药研发IP有限责任公司 | 2017-12-22 | — | — | CN | disclosed |
| CN-102977029-B | As 5 HT2ASerotonin receptor modulator is applied to treat 3 phenylpyrazole derivatives of relative illness | 艾尼纳制药公司 | 2017-12-19 | — | — | CN | disclosed |
| CN-107428935-A | Diamine compound, heat-resistant resin or heat-resistant resin precursor using it | 东丽株式会社 | 2017-12-01 | — | — | CN | disclosed |
| CN-107353289-A | Benzimidazole for electronic application simultaneously [1,2 A] benzimidizole derivatives | UDC 爱尔兰有限责任公司 | 2017-11-17 | — | — | CN | disclosed |
| EP-3240788-A1 | PESTICIDALLY ACTIVE TETRACYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS | Syngenta Participations AG (CH) | 2017-11-08 | — | — | EP | disclosed |
| CN-107207432-A | Pyrroles's sulphonyl analog derivative, its preparation method and its in application pharmaceutically | 江苏柯菲平医药股份有限公司 | 2017-09-26 | — | — | CN | disclosed |
| CN-107207872-A | Phthalein green grass or young crops pigment, coloured composition and colored filter | 东洋油墨SC控股株式会社 | 2017-09-26 | — | — | CN | disclosed |
| CN-105377837-B | N (heteroaryl) sulfamide derivative as S100 inhibitor | 活跃生物技术有限公司 | 2017-08-04 | — | — | CN | disclosed |
| CN-107011401-A | Deoxycholic acid compound and its purification process | 凯瑟拉生物制药有限公司 | 2017-08-04 | — | — | CN | disclosed |
| CN-102119143-B | Amide derivative, pest control agent containing the same, and method of using the pest control agent | 三井化学AGRO株式会社 | 2017-07-21 | — | — | CN | disclosed |
| CN-105061313-B | Androgen receptor modulating compounds | 奥赖恩公司 | 2017-07-18 | — | — | CN | disclosed |
| CN-106955287-A | Composition, purposes and its purification process of deoxycholic acid | 凯瑟拉生物制药有限公司 | 2017-07-18 | — | — | CN | disclosed |
| EP-3169680-A1 | NOVEL 2,5-SUBSTITUTED PYRIMIDINES AS PDE INHIBITORS | Grünenthal GmbH (DE) | 2017-05-24 | — | — | EP | disclosed |
| CN-106687462-A | Processes of preparing a jak1 inhibitor and new forms thereto | 因赛特公司 | 2017-05-17 | — | — | CN | disclosed |
| CN-104379576-B | Substituted pyrrolidines as factor XIA inhibitors for the treatment of thromboembolic disorders | 小野药品工业株式会社 | 2017-05-10 | — | — | CN | disclosed |
| WO-2017065899-A1 | DEUTERATED CHLOROKYNURENINES FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS | AUSPEX PHARMACEUTICALS, INC. (US) | 2017-04-20 | — | — | WO | disclosed |
| CN-104011042-B | Insecticidal triazinone derivatives | 先正达参股股份有限公司 | 2017-03-29 | — | — | CN | disclosed |
| CN-104854087-B | Indole carboxamide derivatives as P2X receptor antagonists | 埃科特莱茵药品有限公司 | 2017-03-22 | — | — | CN | disclosed |
| CN-106536506-A | Benzimidazole derivatives as erbb tyrosine kinase inhibitors for the treatment of cancer | 卡佩拉医疗公司 | 2017-03-22 | — | — | CN | disclosed |
| CN-106488910-A | Inhibitors of kras g12c | 亚瑞克西斯制药公司 | 2017-03-08 | — | — | CN | disclosed |
| CN-106488916-A | The new 2,5 substituted miazines as PDE inhibitor | 格吕伦塔尔有限公司 | 2017-03-08 | — | — | CN | disclosed |
| CN-106467448-A | For the alkene polymerization inhibitor in methanol-to-olefins device caustic wash tower | 中国石油化工股份有限公司 | 2017-03-01 | — | — | CN | disclosed |
| CN-106467447-A | The method of olefinic polymerization in suppression methanol-to-olefins device caustic wash tower | 中国石油化工股份有限公司 | 2017-03-01 | — | — | CN | disclosed |
| CN-103864804-B | Synthetic method for pranoprofen | 天津金耀集团有限公司 | 2017-02-22 | — | — | CN | disclosed |
| CN-106459088-A | 2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8h)-yl-1,3-thiazol-4-yl amides | 辉瑞公司 | 2017-02-22 | — | — | CN | disclosed |
| CN-106414442-A | 1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS | 因赛特公司 | 2017-02-15 | — | — | CN | disclosed |
| WO-2016199020-A1 | PROCESS FOR PREPARATION OF CERITINIB | DR. REDDY'S LABORATORIES LIMITED (IN) | 2016-12-15 | — | — | WO | disclosed |
| EP-3074381-A1 | NOVEL DGAT2 INHIBITORS | Eli Lilly and Company (US) | 2016-10-05 | — | — | EP | disclosed |
| WO-2016131098-A1 | SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME | THE UNIVERSITY OF QUEENSLAND (AU) | 2016-08-25 | — | — | WO | disclosed |
| EP-3044226-A1 | ARYL ETHER-BASE KINASE INHIBITORS | Bristol-Myers Squibb Company (US) | 2016-07-20 | — | — | EP | disclosed |
| WO-2016107742-A1 | PESTICIDALLY ACTIVE TETRACYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS | SYNGENTA PARTICIPATIONS AG (CH) | 2016-07-07 | — | — | WO | disclosed |
| CN-103797024-B | Hepatitis c virus inhibitors | BRISTOL-MYERS SQUIBB CO. (US) | 2016-06-01 | — | — | CN | disclosed |
| WO-2016046782-A1 | IMIDAZOLE BIARYL COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS | GLENMARK PHARMACEUTICALS S.A. (CH) | 2016-03-31 | — | — | WO | disclosed |
| WO-2016008592-A1 | NOVEL 2,5-SUBSTITUTED PYRIMIDINES AS PDE INHIBITORS | Grünenthal GmbH (DE) | 2016-01-21 | — | — | WO | disclosed |
| CN-105176641-A | Tractor three-purpose lubricating oil composition and preparation method of tractor three-purpose lubricating oil composition | CHINA PETROLEUM & CHEMICAL | 2015-12-23 | — | — | CN | disclosed |
| WO-2015191677-A1 | BICYCLIC HETEROARYLAMINOALKYL PHENYL DERIVATIVES AS PI3K INHIBITORS | INCYTE CORPORATION (US) | 2015-12-17 | — | — | WO | disclosed |
| EP-2951170-A2 | FLAP MODULATORS | Janssen Pharmaceutica, N.V. (BE) | 2015-12-09 | — | — | EP | disclosed |
| US-9073901-B2 | DGAT2 inhibitors | ELI LILLY AND COMPANY (US) | 2015-07-07 | — | — | US | disclosed |
| WO-2015077299-A1 | NOVEL DGAT2 INHIBITORS | ELI LILLY AND COMPANY (US) | 2015-05-28 | — | — | WO | disclosed |
| US-20150148358-A1 | NOVEL DGAT2 INHIBITORS | ELI LILLY AND COMPANY (US) | 2015-05-28 | — | — | US | disclosed |
| EP-2855452-A1 | SUBSTITUTED PYRROLIDINES AS FACTOR XIA INHIBITORS FOR THE TREATMENT THROMBOEMBOLIC DISEASES | ONO Pharmaceutical Co., Ltd. (JP) | 2015-04-08 | — | — | EP | disclosed |
| WO-2015038112-A1 | ARYL ETHER-BASE KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2015-03-19 | — | — | WO | disclosed |
| EP-2836487-A1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | Infinity Pharmaceuticals, Inc. (US) | 2015-02-18 | — | — | EP | disclosed |
| EP-2822952-A1 | ARYL ETHER-BASE KINASE INHIBITORS | Bristol-Myers Squibb Company (US) | 2015-01-14 | — | — | EP | disclosed |
| WO-2014121055-A2 | FLAP MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2014-08-07 | — | — | WO | disclosed |
| EP-2697283-A1 | SEMICONDUCTING POLYMERS | University of Chicago (US) | 2014-02-19 | — | — | EP | disclosed |
| WO-2014016847-A1 | A PROCESS FOR THE PREPARATION OF CINACALCET HYDROCHLORIDE AND ITS INTERMEDIATE | TYCHE INDUSTRIES LIMITED (IN) | 2014-01-30 | — | — | WO | disclosed |
| EP-2673285-A1 | KETOLIDE COMPOUNDS | Wockhardt Limited (IN) | 2013-12-18 | — | — | EP | disclosed |
| WO-2013174937-A1 | SUBSTITUTED PYRROLIDINES AS FACTOR XIA INHIBITORS FOR THE TREATMENT THROMBOEMBOLIC DISEASES | ONO PHARMACEUTICAL CO., LTD (JP) | 2013-11-28 | — | — | WO | disclosed |
| WO-2013154878-A1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | INFINITY PHARMACEUTICALS, INC. (US) | 2013-10-17 | — | — | WO | disclosed |
| WO-2013134036-A1 | ARYL ETHER-BASE KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-09-12 | — | — | WO | disclosed |
| CN-102803218-A | 4 -aminopicolinates And Their Use As Herbicides | SYNGENTA LTD | 2012-11-28 | — | — | CN | disclosed |
| EP-2513091-A1 | HEPATITIS C VIRUS INHIBITORS | Bristol-Myers Squibb Company (US) | 2012-10-24 | — | — | EP | disclosed |
| WO-2012142469-A1 | SEMICONDUCTING POLYMERS | UNIVERSITY OF CHICAGO (US) | 2012-10-18 | — | — | WO | disclosed |
| EP-2493866-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS | Bristol-Myers Squibb Company (US) | 2012-09-05 | — | — | EP | disclosed |
| WO-2012076989-A1 | KETOLIDE COMPOUNDS | WOCKHARDT LIMITED (IN) | 2012-06-14 | — | — | WO | disclosed |
| WO-2012038966-A1 | PROCESS FOR THE PREPARATION OF DONEPEZIL INTERMEDIATE | TYCHE INDUSTRIES LTD. (IN) | 2012-03-29 | — | — | WO | disclosed |
| WO-2011075630-A1 | SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS | INCYTE CORPORATION (US) | 2011-06-23 | — | — | WO | disclosed |
| WO-2011075439-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-06-23 | — | — | WO | disclosed |
| WO-2011059784-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-05-19 | — | — | WO | disclosed |
| WO-2011038313-A2 | SELECTIVE OXIDATION OF C-H BONDS OF MODIFIED SUBSTRATES BY P450 MONOOXYGENASE | REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2011-03-31 | — | — | WO | disclosed |
| WO-2010141592-A2 | CHEMICAL FRAGMENT SCREENING AND ASSEMBLY UTILIZING COMMON CHEMISTRY FOR NMR PROBE INTRODUCTION AND FRAGMENT LINKAGE | MARQUETTE UNIVERSITY (US) | 2010-12-09 | — | — | WO | disclosed |
| EP-2225203-A1 | DEHYDROHALOGENATION PROCESS FOR THE PREPARATION OF INTERMEDIATES USEFUL IN PROVIDING 6,6-DIMETHYL-3-AZABICYCLO-[3.1.0]-HEXANE COMPOUNDS | Schering Corporation (US) | 2010-09-08 | — | — | EP | disclosed |
| CN-101743230-A | Arylpyrrol-2-yl cyanoethylamino compounds, process for their preparation and their use | AVENTIS AGRICULTURE | 2010-06-16 | — | — | CN | disclosed |
| WO-2010024980-A1 | 4'-AMINO CYCLIC COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY | MEMORY PHARMACEUTICALS CORPORATION (US) | 2010-03-04 | — | — | WO | disclosed |
| WO-2010021797-A1 | CONDENSED HETEROCYCLIC COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY | MEMORY PHARMACEUTICALS CORPORATION (US) | 2010-02-25 | — | — | WO | disclosed |
| WO-2010011546-A2 | ACYCLIC COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY | MEMORY PHARMACEUTICALS CORPORATION (US) | 2010-01-28 | — | — | WO | disclosed |
| WO-2010008832-A1 | PYRROLO-PYRIDINE-3-YL-PIPERAZINE DERIVATIVES HAVING 5-HT6 RECEPTOR AFFINITY | MEMORY PHARMACEUTICALS CORPORATION (US) | 2010-01-21 | — | — | WO | disclosed |
| WO-2010002802-A1 | PYRROLIDINE-SUBSTITUTED AZAINDOLE COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY | MEMORY PHARMACEUTICALS CORPORATION (US) | 2010-01-07 | — | — | WO | disclosed |
| EP-2125675-A1 | METHODS FOR GASSING EXPLOSIVES ESPECIALLY AT LOW TEMPERATURES | Newcastle Innovation Limited (AU) | 2009-12-02 | — | — | EP | disclosed |
| CN-101568505-A | For treating NO-containing substancesxOr an ethylene oxide stream of an organic nitrogen compound | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2009-10-28 | — | — | CN | disclosed |
| EP-2097362-A1 | PROCESS FOR REDUCING SIDE-REACTIONS DURING ALKYLENE GLYCOL AND POLY-ALKYLENE GLYCOL MANUFACTURING | Dow Technology Investments LLC (US) | 2009-09-09 | — | — | EP | disclosed |
| CN-101528033-A | Cropping systems for managing weeds | MONSANTO TECHNOLOGY LLC (US) | 2009-09-09 | — | — | CN | disclosed |
| CN-101511840-A | Phosphoinositide 3-kinase inhibitor compounds and methods of use thereof | GENENTECH INC (US) | 2009-08-19 | — | — | CN | disclosed |
| WO-2009073380-A1 | DEHYDROHALOGENATION PROCESS FOR THE PREPARATION OF INTERMEDIATES USEFUL IN PROVIDING 6,6-DIMETHYL-3-AZABICYCLO-[3.1.0]-HEXANE COMPOUNDS | SCHERING CORPORATION (US) | 2009-06-11 | — | — | WO | disclosed |
| EP-2029579-A2 | CYCLOHEXYLPYRAZOLE-LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 | ELI LILLY AND COMPANY (US) | 2009-03-04 | — | — | EP | disclosed |
| EP-2021338-A1 | CYCLOALKYLAMINO ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF | Pfizer Products Inc. (US) | 2009-02-11 | — | — | EP | disclosed |
| WO-2008085268-A1 | PROCESS FOR PROCESSING ETHYLENE OXIDE STREAMS CONTAINING NOX OR ORGANIC NITROGEN COMPOUNDS | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2008-07-17 | — | — | WO | disclosed |
| WO-2008085267-A1 | PROCESS FOR REDUCING SIDE-REACTIONS DURING ALKYLENE GLYCOL AND POLY-ALKYLENE GLYCOL MANUFACTURING | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2008-07-17 | — | — | WO | disclosed |
| WO-2008083436-A1 | METHODS FOR GASSING EXPLOSIVES ESPECIALLY AT LOW TEMPERATURES | NEWCASTLE INNOVATION LIMITED (AU) | 2008-07-17 | — | — | WO | disclosed |
| EP-1863494-A1 | USE OF VITAMIN D COMPOUNDS TO TREAT ENDOMETRIOSIS | Bioxell S.p.a. (IT) | 2007-12-12 | — | — | EP | disclosed |
| EP-1858902-A1 | BICYCLIC HETEROAROMATIC DERIVATIVES USEFUL AS ANTICANCER AGENTS | Pfizer Products Incorporated (US) | 2007-11-28 | — | — | EP | disclosed |
| WO-2007132307-A1 | CYCLOALKYLAMINO ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF | PFIZER PRODUCTS INC. (US) | 2007-11-22 | — | — | WO | disclosed |
| WO-2007124254-A2 | CYCLOHEXYLPYRAZOLE-LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 | ELI LILLY AND COMPANY (US) | 2007-11-01 | — | — | WO | disclosed |
| EP-1778634-A1 | ISOINDOLONE COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS | AstraZeneca AB (SE) | 2007-05-02 | — | — | EP | disclosed |
| WO-2006100285-A1 | USE OF VITAMIN D COMPOUNDS TO TREAT ENDOMETRIOSIS | BIOXELL SPA (IT) | 2006-09-28 | — | — | WO | disclosed |
| WO-2006090261-A1 | BICYCLIC HETEROAROMATIC DERIVATIVES USEFUL AS ANTICANCER AGENTS | PFIZER PRODUCTS INC. (US) | 2006-08-31 | — | — | WO | disclosed |
| WO-2006083417-A2 | PROCESSES OF MAKING SESQUITERPENOID TASHIRONIN, ITS ANALOGS AND THEIR USES | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2006-08-10 | — | — | WO | disclosed |
| WO-2006069155-A2 | INHIBITORS OF PROTEIN ARGININE METHYL TRANSFERASES | BRISTOL-MYERS SQUIBB COMPANY (US) | 2006-06-29 | — | — | WO | disclosed |
| WO-2006035075-A1 | USE OF VITAMIN D COMPOUNDS FOR THE PREVENTION OR TREATMENT OF CHRONIC PROSTATITIS | BIOXELL SPA (IT) | 2006-04-06 | — | — | WO | disclosed |
| WO-2006020879-A1 | ISOINDOLONE COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS | ASTRAZENECA AB (SE) | 2006-02-23 | — | — | WO | disclosed |
| EP-1567527-A1 | CONDENSED PYRAZOLO DERIVATIVES | ELI LILLY AND COMPANY (US) | 2005-08-31 | — | — | EP | disclosed |
| EP-1539795-A1 | CRYSTALLINE 17BETA-HYDROXY-7ALPHA-(5'-METHYL-2'-FURYL)-PREGNA-4,9(11)-DIEN-3-ONE-21-CARBOXYLIC ACID, GAMMA-LACTONE | Pharmacia & Upjohn Company LLC (US) | 2005-06-15 | — | — | EP | disclosed |
| EP-1539662-A1 | CANNABINOID RECEPTOR LIGANDS | SCHERING CORPORATION (US) | 2005-06-15 | — | — | EP | disclosed |
| EP-1487859-A2 | PROCESS TO PREPARE EPLERENONE | PHARMACIA & UPJOHN COMPANY (US) | 2004-12-22 | — | — | EP | disclosed |
| WO-2004050659-A1 | NOVEL COMPOUNDS AS PHARMACEUTICAL AGENTS | ELI LILLY AND COMPANY (US) | 2004-06-17 | — | — | WO | disclosed |
| WO-2004037844-A1 | CRYSTALLINE 17BETA-HYDROXY-7ALPHA- (5'-METHYL-2'-FURYL)-PREGNA-4,9(11)-DIEN-3-ONE-21-CARBOXYLIC ACID, GAMMA-LACTONE | PHARMACIA & UPJOHN COMPANY (US) | 2004-05-06 | — | — | WO | disclosed |
| EP-1401820-A1 | 5-HT RECEPTOR LIGANDS AND USES THEREOF | Pfizer Products Inc. (US) | 2004-03-31 | — | — | EP | disclosed |
| WO-2004014825-A1 | CANNABINOID RECEPTOR LIGANDS | SCHERING CORPORATION (US) | 2004-02-19 | — | — | WO | disclosed |
| EP-1373194-A1 | BENZAMIDE INHIBITORS OF FACTOR Xa | Millennium Pharmaceuticals, Inc. (US) | 2004-01-02 | — | — | EP | disclosed |
| EP-1368308-A1 | CANNABINOID RECEPTOR LIGANDS | Schering Corporation (US) | 2003-12-10 | — | — | EP | disclosed |
| WO-2003082895-A2 | PROCESS TO PREPARE EPLERENONE | PHARMACIA & UPJOHN COMPANY (US) | 2003-10-09 | — | — | WO | disclosed |
| WO-2002062750-A9 | CANNABINOID RECEPTOR LIGANDS | SCHERING CORP (US) | 2003-09-18 | — | — | WO | disclosed |
| WO-2003000666-A1 | 5-HT RECEPTOR LIGANDS AND USES THEREOF | PFIZER PRODUCTS INC. (US) | 2003-01-03 | — | — | WO | disclosed |
| WO-2002079145-A1 | BENZAMIDE INHIBITORS OF FACTOR Xa | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2002-10-10 | — | — | WO | disclosed |
| WO-2002062750-A1 | CANNABINOID RECEPTOR LIGANDS | SCHERING CORPORATION (US) | 2002-08-15 | — | — | WO | disclosed |
| EP-1076558-A1 | 2-PHENYL-1-[-(2-AMINOETHOXY)-BENZYL -INDOLE IN COMBINATION WITH ESTROGENS | AMERICAN HOME PRODUCTS CORPORATION (US) | 2001-02-21 | — | — | EP | disclosed |
| EP-1056719-A2 | INHIBITORS OF PHOSPHOLIPASE ENZYMES | GENETICS INSTITUTE, INC. (US) | 2000-12-06 | — | — | EP | disclosed |
| EP-0973749-A1 | 4-AMINOALKOXY-1H-BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS DOPAMINE AUTORECEPTOR (D2) AGONISTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 2000-01-26 | — | — | EP | disclosed |
| EP-0964854-A1 | 4-AMINOALKOXY-1,3-DIHYDROBENZOIMIDAZOL-2-THIONES DERIVATIVES, THEIR PREPARATION AND THEIR USE AS DOPAMINE AUTORECEPTOR (D2) AGONISTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1999-12-22 | — | — | EP | disclosed |
| EP-0964853-A1 | 4-AMINOALKOXY-1,3-DIHYDROBENZOIMIDAZOL-2-ONE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS DOPAMINE AUTORECEPTOR (D2) AGONISTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1999-12-22 | — | — | EP | disclosed |
| WO-1999059581-A1 | 2-PHENYL-1-[4-(2-AMINOETHOXY)-BENZYL]-INDOLE IN COMBINATION WITH ESTROGENS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1999-11-25 | — | — | WO | disclosed |
| EP-0942912-A1 | ANTIBACTERIAL AGENTS | WARNER-LAMBERT COMPANY (US) | 1999-09-22 | — | — | EP | disclosed |
| WO-1999043651-A2 | INHIBITORS OF PHOSPHOLIPASE ENZYMES | GENETICS INSTITUTE, INC. (US) | 1999-09-02 | — | — | WO | disclosed |
| WO-1998035946-A1 | 4-AMINOALKOXY-1,3-DIHYDROBENZOIMIDAZOL-2-ONE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS DOPAMINE AUTORECEPTOR (D2) AGONISTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1998-08-20 | — | — | WO | disclosed |
| WO-1998035947-A1 | 4-AMINOALKOXY-1,3-DIHYDROBENZOIMIDAZOL-2-THIONES DERIVATIVES, THEIR PREPARATION AND THEIR USE AS DOPAMINE AUTORECEPTOR (D2) AGONISTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1998-08-20 | — | — | WO | disclosed |
| WO-1998035945-A1 | 4-AMINOALKOXY-1H-BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS DOPAMINE AUTORECEPTOR (D2) AGONISTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1998-08-20 | — | — | WO | disclosed |
| WO-1998025932-A1 | ANTIBACTERIAL AGENTS | WARNER-LAMBERT COMPANY (US) | 1998-06-18 | — | — | WO | disclosed |
| EP-0691966-A1 | QUINOLINES AS TYPE IV PHOSPHODIESTERASE INHIBITORS | SYNTEX (U.S.A.) INC. (US) | 1996-01-17 | — | — | EP | disclosed |
| WO-1995029904-A1 | SUBSTITUTED THIAZOLE SULFONAMIDES AS ANTIGLAUCOMA AGENTS | ALLERGAN (US) | 1995-11-09 | — | — | WO | disclosed |
| EP-0673360-A1 | AMINOMETHYLINDANS, -BENZOFURANES AND -BENZOTHIOPHENES | H. LUNDBECK A/S (DK) | 1995-09-27 | — | — | EP | disclosed |
| WO-1994013620-A1 | AMINOMETHYLINDANS, -BENZOFURANES AND -BENZOTHIOPHENES | H. LUNDBECK A/S (DK) | 1994-06-23 | — | — | WO | disclosed |
| US-5077394-A | Tetraphenyl-type with electronegative substituents; oxidation catalysts for alkanes and alkenes | SANDOZ LTD. (CH) | 1991-12-31 | — | — | US | disclosed |
| US-4892941-A | OXIDATION CATALYSTS, LIGNIN, HYDROXYLATION, EPOXIDATION | CLARIANT FINANCE (BVI) LIMITED (VG) | 1990-01-09 | — | — | US | disclosed |
| EP-0124461-B1 | METHOD AND COMPOSITION FOR CLEANING AND DECONTAMINATING CONTACT LENSES | Laboratoires P.O.S. Société Anonyme dite: (FR) | 1987-03-18 | — | — | EP | disclosed |
| EP-0124461-B1 | METHOD AND COMPOSITION FOR CLEANING AND DECONTAMINATING CONTACT LENSES | Laboratoires P.O.S. Société Anonyme dite: (FR) | 1987-03-18 | — | — | EP | disclosed |